Aktiesnakken — Oktober 2010
-
max, det er da noget en turnaround case, venue
-
-
ikke et segment man har virkeligt meget tiltro til....
-
gå du og brygger på at han skulle kunne gøre det samme i venue?
-
hele min quota af investeringer i cash brændende firmaer er fuldt op af genmab
-
men jeg tror ikke at de i q4 kan vende det til plus, på trods af at de ikke tager afskrivninger på 9,7
-
jamen det er spændende. Turn around. Jeg vil bare hellere ind i det 2. positive kvartal.
-
Ja biotek er gift for ens pengepung
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Digital Vision er en turn-around case,Venue er,Biosensor er mm